What is the address of TRITOMEDIX?

The registered office of TRITOMEDIX is located at Tritomastraat 39, 1170 Watermaal-Bosvoorde.

Is TRITOMEDIX still active?

Yes. According to the CBE (16 September 2026) TRITOMEDIX is active, legal situation “Normale toestand”, started on 28 October 2008.

Is TRITOMEDIX registered on Peppol?

Yes, TRITOMEDIX is registered on the Peppol network with ID 0208:0807412360.

What is the enterprise number of TRITOMEDIX?

The enterprise number of TRITOMEDIX is BE0807412360.

When was TRITOMEDIX founded?

TRITOMEDIX was founded on 28 October 2008.

Who are the directors of TRITOMEDIX?

According to the 2025 annual accounts, the directors of TRITOMEDIX are: Alain Bouttefeux.

Is TRITOMEDIX a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 October 2008; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did TRITOMEDIX make in 2025?

TRITOMEDIX posted a profit after taxes of € 34,787 in financial year 2025.

What is the revenue of TRITOMEDIX?

As a small company, TRITOMEDIX is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 56,328.

TRITOMEDIX (Private Limited) - Watermaal-Bosvoorde

Dossier TRITOMEDIX, printed on 16 September 2026 from databakkes.be/en/0807412360/tritomedix. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

TRITOMEDIX from Watermaal-Bosvoorde, company number BE0807412360, closed financial year 2025 with a result of € 34,787 after tax. For that financial year TRITOMEDIX recorded a gross margin of € 56,328 and equity of € 198,299. Compared with financial year 2024, the result moved from € 27,468 to € 34,787. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 2, 2026.

What it is worth Growing

€ 198,299

▲ 21% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 34,787

▲ 27% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 34,560

▼ 16% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 179,699.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 4,299

▼ 62% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 3,532

▲ 5% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,111

▲ 15% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 44,412 Gross margin 2022: € 44,412 First fiscal year in the series	€ 33,831 Gross margin 2023: € 33,831 ▼ 24% vs 2022 (€ 44,412) Unfavourable step	€ 49,432 Gross margin 2024: € 49,432 ▲ 46% vs 2023 (€ 33,831) Favourable step	€ 56,328 Gross margin 2025: € 56,328 ▲ 14% vs 2024 (€ 49,432) Favourable step	▲ 14%
Profit after taxes	€ 22,278 Profit after taxes 2022: € 22,278 First fiscal year in the series	€ 15,599 Profit after taxes 2023: € 15,599 ▼ 30% vs 2022 (€ 22,278) Unfavourable step	€ 27,468 Profit after taxes 2024: € 27,468 ▲ 76% vs 2023 (€ 15,599) Favourable step	€ 34,787 Profit after taxes 2025: € 34,787 ▲ 27% vs 2024 (€ 27,468) Favourable step	▲ 27%
Equity	€ 120,445 Equity 2022: € 120,445 First fiscal year in the series	€ 136,044 Equity 2023: € 136,044 ▲ 13% vs 2022 (€ 120,445) Favourable step	€ 163,512 Equity 2024: € 163,512 ▲ 20% vs 2023 (€ 136,044) Favourable step	€ 198,299 Equity 2025: € 198,299 ▲ 21% vs 2024 (€ 163,512) Favourable step	▲ 21%
Total debts	€ 22,019 Total debts 2022: € 22,019 First fiscal year in the series	€ 26,683 Total debts 2023: € 26,683 ▲ 21% vs 2022 (€ 22,019) Unfavourable step	€ 30,234 Total debts 2024: € 30,234 ▲ 13% vs 2023 (€ 26,683) Unfavourable step	€ 25,537 Total debts 2025: € 25,537 ▼ 16% vs 2024 (€ 30,234) Favourable step	▼ 16%
Cash	€ 53,966 Cash 2022: € 53,966 First fiscal year in the series	€ 19,826 Cash 2023: € 19,826 ▼ 63% vs 2022 (€ 53,966) Unfavourable step	€ 41,067 Cash 2024: € 41,067 ▲ 107% vs 2023 (€ 19,826) Favourable step	€ 34,560 Cash 2025: € 34,560 ▼ 16% vs 2024 (€ 41,067) Unfavourable step	▼ 16%
Retained profit	€ 101,845 Retained profit 2022: € 101,845 First fiscal year in the series	€ 117,444 Retained profit 2023: € 117,444 ▲ 15% vs 2022 (€ 101,845) Favourable step	€ 144,912 Retained profit 2024: € 144,912 ▲ 23% vs 2023 (€ 117,444) Favourable step	€ 179,699 Retained profit 2025: € 179,699 ▲ 24% vs 2024 (€ 144,912) Favourable step	▲ 24%
Balance sheet total	€ 142,463 Balance sheet total 2022: € 142,463 First fiscal year in the series	€ 162,727 Balance sheet total 2023: € 162,727 ▲ 14% vs 2022 (€ 142,463) Unchanged	€ 193,746 Balance sheet total 2024: € 193,746 ▲ 19% vs 2023 (€ 162,727) Unchanged	€ 223,836 Balance sheet total 2025: € 223,836 ▲ 16% vs 2024 (€ 193,746) Unchanged	▲ 16%

Key figures of TRITOMEDIX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to TRITOMEDIX?

What happened at TRITOMEDIX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 2, 2026 New annual accounts for financial year 2025: profit of € 34,787 (▲ 27% vs 2024). Source: NBB ↗
Oct 28, 2008 New establishment in Watermaal-Bosvoorde. KBO
Oct 28, 2008 Start of the company according to the CBE. KBO
2008 Alain Bouttefeux became a director. NBB

In short

From € 22,278 profit in 2022 to € 34,787 profit in 2025.

Paid € 45,427 in corporate taxes since 2022.

Best year ever: 2025, with € 34,787 profit.

Original PDFs at the National Bank ↗

A new publication or filing at TRITOMEDIX? We notify you, reason included.

Follow TRITOMEDIX

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Alain Bouttefeux

TRITOMEDIX

Behind TRITOMEDIX is Alain Bouttefeux.

See the full network in the app

Directors

According to the 2025 annual accounts

Alain Bouttefeux

Director

since 2008

Establishments

Establishment units

Physical locations of this company

Registered office

Tritomastraat 39

1170 Watermaal-Bosvoorde

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Medical Association for Personnal Health Improvement(P.H.I.)

Association des copropriétaires à Watermael-Boitsfort, Rue des Tritomas, 39

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0807.412.360
VAT number: BE 0807.412.360
Registered office: Tritomastraat 39, 1170 Watermaal-Bosvoorde
Names & denominations: TRITOMEDIX
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 28 October 2008
Peppol: Active · Active since 13 Nov 2025
Contact: [email protected]

View on CBE Public ↗ Annual accounts (NBB) ↗